title: Inhibition of the compartment syndrome by the ablation of free radical-mediated reperfusion injury.
abstract: Skeletal muscle edema secondary to an increase in capillary permeability after reflow is an important cause of the compartment syndrome after acute arterial revascularization. The purpose of this study was to investigate the possible role of oxygen free radicals, generated at reperfusion, in the pathogenesis of the compartment syndrome secondary to acute arterial ischemia/reperfusion. A reproducible model of this syndrome was produced in anesthetized rabbits by femoral artery occlusion after surgical devascularization of collateral branches from the aorta to the popliteal artery. Increasing periods of ischemia from 6 to 12 hours, followed by 2 hours of reperfusion, were associated with corresponding increases in the anterior muscle compartment hydrostatic pressure and inversely proportional decreases in tibialis anterior muscle blood flow within that compartment as assessed by xenon 133 washout (n = 46) (r = -0.62, p less than 0.001). Anterior compartment pressure increased from 5 +/- 1 to 48 +/- 5 mm Hg (n = 46) (p less than 0.001) after 7 hours of total arterial ischemia and 2 hours of reperfusion. Ablation of free radicals generated from xanthine oxidase with either allopurinol (n = 8) or oxypurinol (n = 8), by scavenging the superoxide radical at reperfusion with superoxide dismutase (n = 8), or by blocking secondary hydroxyl radical formation with deferoxamine (n = 8) significantly ameliorated the rise in compartment pressure (p less than 0.05) in each case; it also significantly improved muscle perfusion in the superoxide dismutase-, allopurinol-, and deferoxamine-treated animals (p less than 0.05). These findings indicate that development of the compartment syndrome after acute arterial revascularization may be due, at least in part, to microvascular injury mediated by oxygen-derived free radicals generated from xanthine oxidase at reperfusion.
authors.affiliation: Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Md. 21205.
authors.forename: B A
authors.initials: BA
authors.lastname: Perler
authors.forename: A G
authors.initials: AG
authors.lastname: Tohmeh
authors.forename: G B
authors.initials: GB
authors.lastname: Bulkley
mesh_terms: D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure; D003161:Compartment Syndromes / Q000517:prevention & control*; D003676:Deferoxamine / Q000494:pharmacology; D005609:Free Radicals; D007511:Ischemia / Q000503:physiopathology; D010100:Oxygen / Q000378:metabolism*; D010117:Oxypurinol / Q000494:pharmacology; D011817:Rabbits; D012039:Regional Blood Flow; D015427:Reperfusion Injury / Q000209:etiology / Q000601:surgery*; D013482:Superoxide Dismutase / Q000494:pharmacology
chemical_list: D005609:Free Radicals; D000493:Allopurinol; D013482:Superoxide Dismutase; D010117:Oxypurinol; D003676:Deferoxamine; D010100:Oxygen